BN Business News
Add your company to Business Communicator →

Innovation & intellectual property · 24/02/2014Updated: 10/17/2026 · 1 min read

U.S. Patent Office Grants Interim Extension for Lawsonia Intracellularis Bacterin Vaccine Patent

Summary

The U.S. Patent and Trademark Office has issued an order granting a one-year interim extension under the Patent Term Adjustment Act for U.S. Patent No. 5,610,059, which covers the Monovalent Lawsonia Intracellularis Bacterin Vaccine

Original source language: Federal Register — Patent and Trademark OfficeOpen original release →

Explore insights

Business insights →